Related Experiment Video
Updated: Aug 5, 2026

Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection
Published on: December 8, 2014
Sustained normalization of hydrogen-positive small intestinal bacterial overgrowth after polyethylene glycol bowel
Kunihiko Yokoyama1, Kentaro Tominaga2, Yuichi Kojima1
1Division of Gastroenterology and Hepatology, Graduate School of Medical and Dental Sciences, Niigata University, 1-757 Asahimachi-Dori, Chuo-ku, Niigata, 951-8510, Niigata, Japan.
Abstract:
Small intestinal bacterial overgrowth (SIBO) is a frequent complication of chronic liver disease with portal hypertension that often persists or recurs despite standard treatments. Polyethylene glycol (PEG)-based bowel preparations are routinely used before colonoscopy; however, their effects on SIBO have not yet been systematically evaluated. We report the case of a 44-year-old man with metabolic dysfunction-associated steatohepatitis, complicated by intrahepatic portal vein thrombosis and esophagogastric varices. Before colonoscopy, hydrogen and methane breath testing revealed hydrogen-positive and methane-negative SIBO, while the gastrointestinal symptoms were mild, with a Gastrointestinal Symptom Rating Scale score of 15. Subsequently, the patient underwent a standard bowel preparation using a PEG electrolyte solution. No antibiotics, probiotics, laxatives, or dietary interventions were administered before or after the procedure. Follow-up breath tests performed 1 week after bowel preparation demonstrated normalization of both hydrogen and methane levels. Importantly, repeat testing at 6 weeks confirmed sustained negativity without any additional interventions. This case highlights a previously unreported phenomenon, suggesting that transient luminal interventions, such as bowel preparation, may influence small intestinal microbial dynamics in selected high-risk patients. This observation should be considered hypothesis-generating, and no conclusions regarding therapeutic efficacy can be drawn from this single case.
Insights
Polyethylene glycol (PEG) bowel preparation may temporarily resolve small intestinal bacterial overgrowth (SIBO) in patients with chronic liver disease. A single case showed SIBO normalization after PEG preparation, lasting six weeks without further treatment.
Area of Science:
- Gastroenterology
- Hepatology
- Microbiology
Background:
- Small intestinal bacterial overgrowth (SIBO) is a common complication in chronic liver disease (CLD) patients with portal hypertension.
- SIBO often persists or recurs despite conventional therapies, impacting patient quality of life.
Purpose of the Study:
- To investigate the potential impact of polyethylene glycol (PEG)-based bowel preparations on SIBO in a patient with CLD.
- To report a novel observation regarding the effect of transient luminal interventions on gut microbiota.
Main Methods:
- A case report of a 44-year-old male with metabolic dysfunction-associated steatohepatitis and portal hypertension.
- Pre- and post-colonoscopy breath testing (hydrogen and methane) to assess SIBO.
- Standard PEG-based bowel preparation administered prior to colonoscopy.
Main Results:
- Initial breath tests confirmed hydrogen-positive, methane-negative SIBO.
- One week after PEG bowel preparation, breath tests normalized, indicating SIBO resolution.
- SIBO remained resolved at six-week follow-up without additional interventions.
Conclusions:
- This case suggests PEG bowel preparation may transiently impact small intestinal microbial composition.
- Further research is needed to explore this phenomenon as a potential therapeutic avenue for SIBO in high-risk patients.
Related Concept Videos
Endoscopic Procedures IV: Sigmoidoscopy and Laproscopy
Sigmoidoscopy
Sigmoidoscopy is a diagnostic procedure that uses a flexible sigmoidoscope equipped with a light source and camera to examine the rectum and sigmoid colon. The procedure involves inserting the tube through the anus...
Drugs for Treatment of Constipation-Predominant IBS
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Drugs Affecting GI Tract Motility: Other Laxatives
Osmotic or saline laxatives, like magnesium hydroxide or milk of...
Microbiota Modulation by Antibiotics